HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Laura Adamoli Selected Research
Laura Adamoli Research Topics
Disease
13
Breast Neoplasms (Breast Cancer)
06/2015 - 02/2006
8
Neoplasms (Cancer)
09/2014 - 11/2006
3
Disease Progression
11/2012 - 11/2007
2
Circulating Neoplastic Cells
09/2014 - 10/2010
1
Rectal Neoplasms (Rectal Cancer)
09/2014
1
Neoplasm Metastasis (Metastasis)
01/2014
1
Hypertension (High Blood Pressure)
08/2013
1
Triple Negative Breast Neoplasms
08/2013
1
Brain Neoplasms (Brain Tumor)
01/2013
1
Cardiovascular Diseases (Cardiovascular Disease)
11/2012
1
Pain (Aches)
11/2006
1
Lymphangitis
11/2006
Drug/Important Bio-Agent (IBA)
3
Trastuzumab (Herceptin)
FDA Link
02/2014 - 01/2012
2
Vinorelbine (Navelbine)
FDA Link
Generic
06/2015 - 02/2006
2
Capecitabine (Xeloda)
FDA Link
06/2015 - 02/2006
2
Antigens
IBA
02/2014 - 10/2010
2
Progesterone Receptors (Progesterone Receptor)
IBA
01/2014 - 10/2012
2
Hormones (Hormone)
IBA
02/2013 - 01/2012
2
Biological Products
IBA
01/2013 - 10/2012
2
Estrogen Receptors
IBA
10/2012 - 09/2012
2
Fulvestrant (Faslodex)
FDA Link
09/2012 - 11/2007
1
Bevacizumab (Avastin)
FDA Link
06/2015
1
Estramustine
FDA Link
02/2015
1
Cancer Vaccines
IBA
02/2014
1
Antibodies
IBA
02/2014
1
Neoplasm Antigens (Tumor Antigens)
IBA
02/2014
1
human ERBB2 protein
IBA
01/2014
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
08/2013
1
Antihypertensive Agents (Antihypertensives)
IBA
08/2013
1
Therapeutic Uses
IBA
08/2013
1
thiamine triphosphorate (TTP)
IBA
11/2012
1
Epidermal Growth Factor (EGF)
IBA
10/2012
1
Phenobarbital (Luminal)
FDA Link
10/2012
1
Methotrexate (Mexate)
FDA Link
Generic
09/2012
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
09/2012
1
Pharmaceutical Preparations
IBA
11/2007
1
Morphine (MS Contin)
FDA Link
Generic
11/2006
1
Dexamethasone (Maxidex)
FDA Link
Generic
11/2006
1
Analgesics (Analgesic Drugs)
IBA
11/2006
1
Tyrosine Kinase Inhibitors
IBA
11/2006
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
11/2006
1
ErbB Receptors (EGF Receptor)
IBA
11/2006
Therapy/Procedure
6
Therapeutics
06/2015 - 01/2012
5
Drug Therapy (Chemotherapy)
06/2015 - 11/2006
1
Neoadjuvant Therapy
09/2014
1
Immunotherapy
02/2014
1
Cell- and Tissue-Based Therapy (Cell Therapy)
02/2014
1
Radiotherapy
01/2013
1
Subcutaneous Mastectomy
11/2006
1
Adjuvant Chemotherapy
11/2006